| Chasing molecular glue degraders: screening approaches A Domostegui, L Nieto-Barrado, C Perez-Lopez, C Mayor-Ruiz Chemical Society Reviews 51 (13), 5498-5517, 2022 | 72 | 2022 |
| Identification of plitidepsin as potent inhibitor of SARS-CoV-2-induced cytopathic effect after a drug repurposing screen J Rodon, J Muñoz-Basagoiti, D Perez-Zsolt, M Noguera-Julian, ... Frontiers in pharmacology 12, 646676, 2021 | 49 | 2021 |
| FragPELE: dynamic ligand growing within a binding site. A novel tool for hit-to-Lead drug design C Perez, D Soler, R Soliva, V Guallar Journal of Chemical Information and Modeling 60 (3), 1728-1736, 2020 | 17 | 2020 |
| Biophysical and computational approaches to study ternary complexes: a ‘cooperative relationship’to rationalize targeted protein degradation JA Ward, C Perez‐Lopez, C Mayor‐Ruiz ChemBioChem 24 (10), e202300163, 2023 | 15 | 2023 |
| Combining machine‐learning and molecular‐modeling methods for drug‐target affinity predictions C Perez‐Lopez, A Molina, E Lozoya, V Segarra, M Municoy, V Guallar Wiley Interdisciplinary Reviews: Computational Molecular Science 13 (4), e1653, 2023 | 4 | 2023 |
| Known evolutionary paths are accessible to engineered ß-lactamases having altered protein motions at the timescale of catalytic turnover L Alejaldre, C Lemay-St-Denis, C Perez Lopez, F Sancho Jordar, ... Frontiers in Molecular Biosciences 7, 354, 2020 | 3 | 2020 |
| Recent PELE Developments and Applications in Drug Discovery Campaigns I Puch-Giner, A Molina, M Municoy, C Pérez, V Guallar International Journal of Molecular Sciences 23 (24), 16090, 2022 | 1 | 2022 |
| Discovery and Mechanistic Elucidation of NQO1‐Bioactivatable Small Molecules That Overcome Resistance to Degraders BMG Barbosa, A Sfyaki, S Rafael, F José-Duran, J Pous, ... Angewandte Chemie International Edition, e202316730, 2023 | | 2023 |
| Development and application of computer-aided strategies for virtual screening and hit-to-lead CP López Universitat de Barcelona, 2022 | | 2022 |
| FrAG-PELE: novel fragment-based growing tool for hit-to-lead in early drug discovery C Pérez López, V Guallar Book of abstracts, 48-49, 2018 | | 2018 |
